Robert L. Ferrara - Dec 2, 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Dec 2, 2022
Transactions value $
$2,041
Form type
4
Date filed
12/5/2022, 03:30 PM
Previous filing
Nov 28, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $2.04K +5K +20% $0.41 30K Dec 2, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.4075 to $0.4089. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Includes shares of common stock underlying unvested restricted stock units.